Skip to main content
. 2021 May 12;8:661891. doi: 10.3389/fmed.2021.661891

Table 2.

Top 5 causative drug categories responsible for acute and chronic SOCs in SJS/TEN patients.

Name of causative drugs No. of patients (%)
Acute SOCs N = 67
Antiepileptics 15 (22.4)
  Phenytoin 2 (3.0)
  Carbamazepine 4 (6.0)
  Oxcarbazepine 5 (7.5)
  Lamotrigine 2 (3.0)
  Zonisamide 2 (3.0)
Antibiotics 12 (17.9)
  Cephalexin 1 (1.5)
  Cefuroxime 1 (1.5)
  Ceftazidime 1 (1.5)
  Ceftriaxone 1 (1.5)
  Norfloxacin 1 (1.5)
  Levofloxacin 1 (1.5)
  Moxifloxacin 1 (1.5)
  Amoxicillin 3 (4.5)
  Vancomycin 2 (3.0)
Allopurinol 8 (11.9)
NSAIDs 7 (10.4)
  Diclofenac 3 (4.5)
  Ibuprofen 1 (1.5)
  Mefenamic acid 3 (4.5)
Sulfa drugs 6 (9.0)
  Sulfasalazine 3 (4.5)
  Sulfonamide 3 (4.5)
Miscellaneous 19 (28.4)
Chronic SOCs N = 9
NSAIDs 4 (44.4)
Diclofenac 2 (22.2)
Mefenamic acid 1 (11.1)
Cold medicine 19 (11.1)
Anti-epileptics 2 (22.2)
Carbamazepine 1 (11.1)
Lamotrigine 1 (11.1)
Antibiotics
Cefuroxime 1 (11.1)
Sulfa drugs
Sulfasalazine 1 (11.1)
Tenofovir 1 (11.1)

SOCs, Severe ocular complications.

NSAIDs, Non-steroidal anti-inflammatory drugs.